Non-small cell lung cancer, squamous

C3_NSCLC_SQUAM

non-small cell lung carcinoma: A group of at least three distinct histological types of lung cancer, including non-small cell squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. Non-small cell lung carcinomas have a poor response to conventional chemotherapy.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions

HLP_C3_NSCLC_SQUAM

995

Filter registries

Cause of death: ICD-10 C34

Cause of death: ICD-9 162

Cause of death: ICD-8 162

Cancer registry: Topography ICD-O-3 C34

Cancer registry: Morphology ICD-O-3 8070

Cancer registry: Behaviour codes 3

995

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions C.O.D: 10, 8, 9

995

Check minimum number of events None

995

Include endpoints None

995

C3_NSCLC_SQUAM

Extra metadata

Level in the ICD hierarchy C

First used in FinnGen datafreeze DF4

Similar endpoints

↥

List of similar endpoints to Non-small cell lung cancer, squamous based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	965	127	838
Unadjusted prevalence (%)	0.31	0.07	0.62
Mean age at first event (years)	70.53	68.91	70.78

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	-	-	-	-
15 years	-	-	-	-
5 years	-	-	-	-
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: C3_NSCLC_SQUAM – Non-small cell lung cancer, squamous
GWS hits: 1

Survival analyses between endpoints

↥

Plot

before Non-small cell lung cancer, squamous
after Non-small cell lung cancer, squamous

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Non-small cell lung cancer, squamous

↥